Gut Bacteria as Predictors of Early Inflammatory Bowel Disease Course
Studies whether gut bacteria predict how inflammatory bowel disease progresses in adults.
Plain-language title generated from the registry record
Registry title: Early Inflammatory Bowel Disease Progression
Key facts
- Where
- Santiago, ChileSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have had stomach and bowel symptoms for at least 3 weeks. It studies gut bacteria to predict how inflammatory bowel disease goes in the first year after diagnosis.
- Age
- 18 Years to 100 Years
- Sex
- All sexes can join.
- Disease stage
- Early disease: at least 3 weeks of symptoms such as diarrhea, rectal bleeding, abdominal pain, tenesmus or urgency.
Main reasons for not taking part
- Confirmed infectious disease of the gastrointestinal tract
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT06756100, who can take part
Where in Chile
- Pontificia Universidad Catolica of ChileSantiago, ChileTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Pontificia Universidad Catolica de Chile
- Trial code
- NCT06756100
- Record updated
- 1 January 2025
- Original description
The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.Read full original descriptionShow less
Composition and Metabolic Activity of Gut Microbiota to Predict Early Inflammatory Bowel Disease Progression
The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.
Inclusion: Adult patients with with at least 3 weeks of gastrointestinal symptoms including diarrhea, rectal bleeding, abdominal pain, tenesmus or urgency.
Exclusion: Confirmed infectious disease of the gastrointestinal tract.